Vertaling van "randomised noninferiortiy trial and meta-analysis " (Nederlands → Frans) :

(Glasier 2010) Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levenorgestrel for emergency contraception: a randomised noninferiortiy trial and meta-analysis.
(Gallo 2008/2011) Gallo MF, Nanda K, Grimes DA et al. 20 μg versus > 20 μg estrogen combined oral contraceptives for

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
DOI : 10.1002/ 14651858.CD008143.pub2. Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

active forms of vitamin D: a meta-analysis of randomised controlled trials.
forms of vitamin D: a meta-analysis of randomised controlled trials.

DOI: 10.1002/14651858.CD000254.pub3. Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

Bespreking van: – Bischoff-Ferrari HA, Dawson-Hughes B, Stahelin HB et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b3692.
Analyse de: ‐ Bischoff-Ferrari HA, Dawson-Hughes B, Stahelin HB et al. Fall prevention with supplemental and active forms of

Chang A, Lasserson T, Kiljander T et al. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions
10. Chang A, Lasserson T, Kiljander T et al. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions

Winblad B, Jones RW, Wirth Y, Stöffler A, Möbius HJ. Memantine in moderate to severe Alzheimer’s disease: a meta-analysis of randomised clinical trials.
Winblad B, Jones RW, Wirth Y et al. Memantine in moderate to severe Alzheimer’s disease: a meta-analysis of randomised clinical trials.

scope and purpose: 10/12 stakeholders involvement: 8/16 rigour of development: 7/28 (methods available only on request) clarity and presentation: 8/16 applicability: 3/12 editorial independence: 2/8 question: adequate search: insufficient selection: unclear quality appraisal: fair data-extraction: not given characteristics of original studies: not given meta-analysis: no pooling Randomisation: good concealment of allocation: no Blinding of outcome assessors: unclear Baseline characteristics comparable: yes Follow-up: sufficient Intention-to-treat: yes Contamination: unclear
scope and purpose: 10/12 stakeholders involvement: 8/16 rigour of development: 7/28 (methods available only on request) clarity and presentation: 8/16 applicability: 3/12 editorial independence: 2/8 question: adequate search: insufficient selection: unclear quality appraisal: fair data-extraction: not given characteristics of original studies: not given meta-analysis: no pooling

Table 8: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)
Table 10: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)